大葉大學圖書館 |

Pathogenesis and treatment in IgA nephropathy[electronic resource] :an international comparison /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.61
書名/作者:	Pathogenesis and treatment in IgA nephropathy : an international comparison // edited by Yasuhiko Tomino.
其他作者:	Tomino, Yasuhiko.
出版者:	Tokyo : : Springer Japan :, 2016.
面頁冊數:	xi, 342 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	IgA glomerulonephritis.
標題:	IgA glomerulonephritis - Treatment.
標題:	Medicine & Public Health.
標題:	Nephrology.
標題:	Urology.
ISBN:	9784431555889
ISBN:	9784431555872
摘要、提要註:	This book discusses the latest findings on the pathogenesis and treatment of IgA nephropathy. It particularly focuses on recently recognized initiation and progression factors and the varying treatment strategies in different regions, such as Asia, Europe, and the United States. More than 40 years have passed since Dr. Jean Berger first described primary IgA nephropathy ("Nephropathy with mesangial IgA-IgG deposits") as a new disease entity. Immunohistopathologically, IgA nephropathy is characterized by the granular deposition of IgA (IgA1) and C3 in the glomerular mesangial areas with mesangial cell proliferation and the expansion of mesangial matrices. It is clear that IgA nephropathy is one of the most common types of chronic glomerulonephritis in the world. This disease may lead to end-stage kidney disease, with its enormous economic impact on healthcare everywhere. Efforts by many investigators around the world have gradually clarified various aspects of the pathogenesis and treatment of IgA nephropathy. However, there are many controversial strategies for the treatment of patients with IgA nephropathy throughout the world, as there are several limitations for treatment in each country. This volume provides nephrologists everywhere with an overview and comparison of both global and regional findings in basic and clinical fields in IgA nephropathy. It covers genetic variation, aberrant IgA1 production, and classification etiology, guidelines, and treatment goals, with all chapters written by top international researchers.
電子資源:	http://dx.doi.org/10.1007/978-4-431-55588-9

Pathogenesis and treatment in IgA nephropathy[electronic resource] :an international comparison /
Pathogenesis and treatment in IgA nephropathyan international comparison /[electronic resource] :edited by Yasuhiko Tomino. - Tokyo :Springer Japan :2016. - xi, 342 p. :ill. (some col.), digital ;24 cm.

This book discusses the latest findings on the pathogenesis and treatment of IgA nephropathy. It particularly focuses on recently recognized initiation and progression factors and the varying treatment strategies in different regions, such as Asia, Europe, and the United States. More than 40 years have passed since Dr. Jean Berger first described primary IgA nephropathy ("Nephropathy with mesangial IgA-IgG deposits") as a new disease entity. Immunohistopathologically, IgA nephropathy is characterized by the granular deposition of IgA (IgA1) and C3 in the glomerular mesangial areas with mesangial cell proliferation and the expansion of mesangial matrices. It is clear that IgA nephropathy is one of the most common types of chronic glomerulonephritis in the world. This disease may lead to end-stage kidney disease, with its enormous economic impact on healthcare everywhere. Efforts by many investigators around the world have gradually clarified various aspects of the pathogenesis and treatment of IgA nephropathy. However, there are many controversial strategies for the treatment of patients with IgA nephropathy throughout the world, as there are several limitations for treatment in each country. This volume provides nephrologists everywhere with an overview and comparison of both global and regional findings in basic and clinical fields in IgA nephropathy. It covers genetic variation, aberrant IgA1 production, and classification etiology, guidelines, and treatment goals, with all chapters written by top international researchers.

ISBN: 9784431555889

Standard No.: 10.1007/978-4-431-55588-9doiSubjects--Topical Terms:

560910
IgA glomerulonephritis.

LC Class. No.: RC918.I35

Dewey Class. No.: 616.61

Pathogenesis and treatment in IgA nephropathy[electronic resource] :an international comparison /
LDR:02496nam a2200301 a 4500 001 446906
003 DE-He213
005 20160926085521.0
006 m d
007 cr nn 008maaau
008 161201s2016 ja s 0 eng d
020 $a 9784431555889 $q (electronic bk.)
020 $a 9784431555872 $q (paper)
024 7 $a 10.1007/978-4-431-55588-9 $2 doi
035 $a 978-4-431-55588-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC918.I35
072 7 $a MJR $2 bicssc
072 7 $a MED055000 $2 bisacsh
082 0 4 $a 616.61 $2 23
090 $a RC918.I35 $b P297 2016
245 0 0 $a Pathogenesis and treatment in IgA nephropathy $h [electronic resource] : $b an international comparison / $c edited by Yasuhiko Tomino.
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a xi, 342 p. : $b ill. (some col.), digital ; $c 24 cm.
520 $a This book discusses the latest findings on the pathogenesis and treatment of IgA nephropathy. It particularly focuses on recently recognized initiation and progression factors and the varying treatment strategies in different regions, such as Asia, Europe, and the United States. More than 40 years have passed since Dr. Jean Berger first described primary IgA nephropathy ("Nephropathy with mesangial IgA-IgG deposits") as a new disease entity. Immunohistopathologically, IgA nephropathy is characterized by the granular deposition of IgA (IgA1) and C3 in the glomerular mesangial areas with mesangial cell proliferation and the expansion of mesangial matrices. It is clear that IgA nephropathy is one of the most common types of chronic glomerulonephritis in the world. This disease may lead to end-stage kidney disease, with its enormous economic impact on healthcare everywhere. Efforts by many investigators around the world have gradually clarified various aspects of the pathogenesis and treatment of IgA nephropathy. However, there are many controversial strategies for the treatment of patients with IgA nephropathy throughout the world, as there are several limitations for treatment in each country. This volume provides nephrologists everywhere with an overview and comparison of both global and regional findings in basic and clinical fields in IgA nephropathy. It covers genetic variation, aberrant IgA1 production, and classification etiology, guidelines, and treatment goals, with all chapters written by top international researchers.
650 0 $a IgA glomerulonephritis. $3 560910
650 0 $a IgA glomerulonephritis $x Treatment. $3 639997
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Nephrology. $3 431316
650 2 4 $a Urology. $3 403368
700 1 $a Tomino, Yasuhiko. $3 639996
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55588-9
950 $a Medicine (Springer-11650)